CERO(Delisted)
CERo Therapeutics·NASDAQ
--
--(--)
4.85 / 10
Netural
Technical analysis shows mixed signals (4.85/10) with RSI/WR oversold (6.36/6.16) offsetting bearish long shadows (3.82/3.05). Projected neutral trend with cautious bias.
Analysis Checks(2/4)
Long Upper Shadow
Score3.82/10
Win Rate54.69%
Hist. Signals64
Avg Return0.23%
Score3.82/10
Win Rate54.69%
Hist. Signals64
Avg Return0.23%
WR Oversold
Score6.16/10
Win Rate57.26%
Hist. Signals117
Avg Return0.14%
Score6.16/10
Win Rate57.26%
Hist. Signals117
Avg Return0.14%
Long Lower Shadow
Score3.05/10
Win Rate50.70%
Hist. Signals71
Avg Return-0.10%
Score3.05/10
Win Rate50.70%
Hist. Signals71
Avg Return-0.10%
RSI Oversold
Score6.36/10
Win Rate58.62%
Hist. Signals29
Avg Return0.21%
Score6.36/10
Win Rate58.62%
Hist. Signals29
Avg Return0.21%
Long Upper Shadow
Score3.82/10
Win Rate54.69%
Hist. Signals64
Avg Return0.23%
Score3.82/10
Win Rate54.69%
Hist. Signals64
Avg Return0.23%
Long Lower Shadow
Score3.05/10
Win Rate50.70%
Hist. Signals71
Avg Return-0.10%
Score3.05/10
Win Rate50.70%
Hist. Signals71
Avg Return-0.10%
WR Oversold
Score6.16/10
Win Rate57.26%
Hist. Signals117
Avg Return0.14%
Score6.16/10
Win Rate57.26%
Hist. Signals117
Avg Return0.14%
RSI Oversold
Score6.36/10
Win Rate58.62%
Hist. Signals29
Avg Return0.21%
Score6.36/10
Win Rate58.62%
Hist. Signals29
Avg Return0.21%
Technical Analysis of CERO?
- CERO presents a Netural setup with a Technical Score of 4.85/10. Key technical indicators highlight an RSI of 0.00 and a MACD of 0.00, with the trend anchored by the 50-Day SMA at 0.00.
